Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 10 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02948582Phase 2Results posted
• A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPDCompletedNCT02937584Phase 3Results posted
• OTIVACTO Spain Non Interventional StudyCompletedNCT02927795Results posted
• De-implementing Inhaled Steroids to Improve Care and Safety in COPDCompletedNCT02896257Not applicableResults posted
• Pulmonary Rehabilitation Before Lung Cancer ResectionTerminatedNCT02887521Phase 3Results posted
• RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeCompletedNCT02867761Phase 3Results posted
• Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02864407Results posted
• Adherence Study in COPD PatientsCompletedNCT02864342Phase 4Results posted
• Hepatitis C Virus(HCV) Heart and Lung StudyCompletedNCT02858180Phase 4Results posted
• Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsCompletedNCT02853123Phase 4Results posted
• Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02850978Results posted
• The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary DiseaseCompletedNCT02845752Phase 4Results posted
• HFNC Effect on BCSS in Patients With COPDTerminatedNCT02825043Not applicableResults posted
• Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsCompletedNCT02814656Phase 1Results posted
• Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)TerminatedNCT02813447Not applicableResults posted
• An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD PatientsCompletedNCT02799784Phase 4Results posted
• AMPLIFY - D6571C00001 Duaklir USA Phase III StudyCompletedNCT02796677Phase 3Results posted
• Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)CompletedNCT02796651Phase 2Results posted
• Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary PathologyCompletedNCT02787863Phase 4Results posted
• Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02786927Phase 4Results posted
• Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot StudyCompletedNCT02783768Early Phase 1Results posted
• Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary DiseaseCompletedNCT02774226Phase 2Results posted
• Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02729051Phase 3Results posted
• Stage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyTerminatedNCT02722304Phase 3Results posted
• Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)TerminatedNCT02720757Results posted
• OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)CompletedNCT02719639Results posted
• Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT02719184Results posted
• Advancing Symptom Alleviation With Palliative TreatmentCompletedNCT02713347Not applicableResults posted
• The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD PatientsTerminatedNCT02707770Not applicableResults posted
• Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary DiseaseCompletedNCT02700919Phase 2Results posted
• SATisfaction and Adherence to COPD TreatmentCompletedNCT02689492Results posted
• Airway Effects of Tiotropium in Patients With COPDCompletedNCT02683668Phase 3Results posted
• Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPDCompletedNCT02683109Phase 4Results posted
• The Use of High Frequency Oscillations With NIV in Hypercapnic COPD ParticipantsTerminatedNCT02680639Not applicableResults posted
• Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical PracticeCompletedNCT02675517Results posted
• A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02662582Phase 2Results posted
• A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male SubjectsCompletedNCT02648438Phase 1Results posted
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese MenCompletedNCT02645253Phase 1Results posted
• Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPDCompletedNCT02642614Phase 1Results posted
• QVA Mechanistic Efficacy Study (Receptor Effects, Etc)CompletedNCT02634983Phase 4Results posted
• INtervention Study In overweiGHT Patients With COPDCompletedNCT02634268Not applicableResults posted
• Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsCompletedNCT02629965Phase 3Results posted
• A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary DiseaseTerminatedNCT02628769Phase 2Results posted
• Pragmatic Trial of Video Education in Nursing HomesCompletedNCT02612688Not applicableResults posted
• Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPDCompletedNCT02603393Phase 4Results posted
• Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler DevicesCompletedNCT02596009Phase 4Results posted
• Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseTerminatedNCT02587351Phase 3Results posted
• Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD SubjectsCompletedNCT02586493Phase 4Results posted
• Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow ObstructionCompletedNCT02579772Phase 4Results posted
• Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary DiseaseCompletedNCT02573870Phase 2Results posted
• Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02570165Phase 2Results posted
• A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled AsthmaCompletedNCT02567708Phase 2Results posted
• Home-Based Health Management of COPD PatientsCompletedNCT02557178Not applicableResults posted
• Nasal High Flow Therapy 30 Day Readmission StudyTerminatedNCT02552732Not applicableResults posted
• Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02551224Not applicableResults posted
• A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02546700Phase 2Results posted
• Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT02536508Phase 3Results posted
• Phase IV O2 Consumption Study in COPD Patients.CompletedNCT02533505Phase 4Results posted
• A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute ExacerbationCompletedNCT02522299Phase 2Results posted
• A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02518139Phase 3Results posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02512510Phase 3Results posted
• Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT02512302Phase 1Results posted
• Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT02487498Phase 3Results posted
• Efficacy and Safety Study of QVA149 in COPD PatientsCompletedNCT02487446Phase 3Results posted
• Walk On! Physical Activity CoachingCompletedNCT02478359Not applicableResults posted
• Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPDCompletedNCT02464059Phase 2Results posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02459080Phase 3Results posted
• A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251CompletedNCT02449018Phase 2Results posted
• Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT02447575Not applicableResults posted
• Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD PatientsCompletedNCT02442206Phase 4Results posted
• Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011)CompletedNCT02441114Phase 1Results posted
• Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD PatientsCompletedNCT02424344Phase 4Results posted
• Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of ExacerbationsCompletedNCT02418468Phase 4Results posted
• The Trajectory of Physical Activity Following Pulmonary RehabilitationCompletedNCT02399254Results posted
• BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGHCompletedNCT02375724Phase 4Results posted
• A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDCompletedNCT02371629Phase 4Results posted
• An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseaseTerminatedNCT02366637Phase 2Results posted
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)CompletedNCT02347774Phase 3Results posted
• A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02345161Phase 3Results posted
• Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPDCompletedNCT02343458Phase 3Results posted
• Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD PatientsCompletedNCT02331940Not applicableResults posted
• Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary SyndromesCompletedNCT02324660Not applicableResults posted
• Juno Perth Clinical TrialTerminatedNCT02317042Not applicableResults posted
• Targeted Retreatment of COPD ExacerbationsCompletedNCT02300220Phase 3Results posted
• Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02299375Phase 2Results posted
• Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedNCT02296138Phase 3Results posted
• An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT02294734Phase 2Results posted
• Pre/Post Pilot Test of Video Module EducationCompletedNCT02278237Not applicableResults posted
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPDCompletedNCT02276222Phase 3Results posted
• A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsTerminatedNCT02275481Phase 4Results posted
• A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02275052Phase 4Results posted
• A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD PatientsCompletedNCT02272634Phase 2Results posted
• Nebulized Hypertonic Saline for Inpatient Use in COPDCompletedNCT02266875Phase 4Results posted
• Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) StudyCompletedNCT02261727Phase 4Results posted
• Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus TiotropiumCompletedNCT02257385Phase 3Results posted
• A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02257372Phase 4Results posted
• The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary DiseaseCompletedNCT02252588Phase 2Results posted
• Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSACompletedNCT02244957Not applicableResults posted
• Sustainability of Pulmonary Rehab GainsCompletedNCT02241733Not applicableResults posted
• Pulmonary Embolism as a Cause of COPD ExacerbationsCompletedNCT02238639Not applicableResults posted

← Pulmonary Disease, Chronic Obstructive overview